Lipocine Stock Today

LPCN Stock  USD 5.13  0.12  2.40%   

Performance

15 of 100

 
Low
 
High
Good

Odds Of Distress

Less than 33

 
100  
 
Zero
Below Average
Lipocine is selling at 5.13 as of the 28th of March 2024; that is 2.40 percent increase since the beginning of the trading day. The stock's open price was 5.01. Lipocine has about a 33 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. Equity ratings for Lipocine are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of July 2022 and ending today, the 28th of March 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
22nd of October 2013
Category
Healthcare
Classification
Health Care
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The companys pipeline candidates also include LPCN 1144, an oral prodrug of bioidentical testosterone that has completed Phase II clinical trial for the treatment of non-cirrhotic non-alcoholic steatohepatitis LPCN 1111, an oral prodrug of testosterone tridecanoate for once daily dosing, which has completed Phase II clinical trial in hypogonadal men LPCN 1148, a novel prodrug of testosterone and testosterone laurate for the management of decompensated cirrhosis LPCN 1154, an investigational new drug application to conduct a Phase 2 study in Postpartum depression LPCN 2101 for women with epilepsy, which has completed pre-clinical study and LPCN 1107, an oral hydroxyprogesterone caproate product that has completed dose finding Phase II clinical trial for the prevention of recurrent preterm birth. The company has 5.32 M outstanding shares of which 123.61 K shares are now shorted by private and institutional investors with about 8.0 trading days to cover. More on Lipocine

Moving against Lipocine Stock

  0.82MBRX Moleculin Biotech Upward RallyPairCorr
  0.8MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.79MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.75DBVT DBV Technologies Financial Report 2nd of May 2024 PairCorr
  0.69VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.66KA Kineta Inc Report 29th of March 2024 PairCorr
  0.66CALT Calliditas Therapeutics Financial Report 21st of May 2024 PairCorr

Lipocine Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Lipocine's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Lipocine or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ChairmanMahesh Patel
Thematic Ideas
(View all Themes)
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, IT, Biotech, Health Management, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering Lipocine report their recommendations after researching Lipocine's financial statements, talking to executives and customers, or listening in on Lipocine's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Lipocine. The Lipocine consensus assessment is calculated by taking the average forecast from all of the analysts covering Lipocine.
Financial Strength
Based on the measurements of operating efficiency obtained from Lipocine's historical financial statements, Lipocine may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Lipocine is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.00450.0048
Notably Down
Pretty Stable
Total Current Liabilities3.4 M2.6 M
Significantly Up
Slightly volatile
Total Assets29.7 M23 M
Significantly Up
Slightly volatile
Total Current Assets28.8 M22.9 M
Significantly Up
Slightly volatile
Lipocine's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Lipocine's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Lipocine's financial leverage. It provides some insight into what part of Lipocine's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Lipocine's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Lipocine deploys its capital and how much of that capital is borrowed.
Liquidity
Lipocine cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 17.17 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Lipocine has a current ratio of 21.79, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Lipocine until it has trouble settling it off, either with new capital or with free cash flow. So, Lipocine's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Lipocine sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Lipocine to invest in growth at high rates of return. When we think about Lipocine's use of debt, we should always consider it together with cash and equity.

Total Cash From Operating Activities

(12.46 Million)
Lipocine (LPCN) is traded on NASDAQ Exchange in USA. It is located in 675 Arapeen Drive, Salt Lake City, UT, United States, 84108 and employs 17 people. Lipocine is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 26.63 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lipocine's market, we take the total number of its shares issued and multiply it by Lipocine's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Lipocine conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 5.32 M outstanding shares of which 123.61 K shares are now shorted by private and institutional investors with about 8.0 trading days to cover. Lipocine currently holds about 37.4 M in cash with (11.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.42.
Check Lipocine Probability Of Bankruptcy
Ownership Allocation
Lipocine holds a total of 5.32 Million outstanding shares. Lipocine secures 3.03 % of its outstanding shares held by insiders and 9.16 % owned by institutional investors. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Lipocine Ownership Details

Lipocine Stock Price Odds Analysis

Contingent on a normal probability distribution, the odds of Lipocine jumping above the current price in 90 days from now is near 1%. The Lipocine probability density function shows the probability of Lipocine stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Lipocine has a beta of -0.4336. This indicates as returns on benchmark increase, returns on holding Lipocine are expected to decrease at a much lower rate. During the bear market, however, Lipocine is likely to outperform the market. Moreover, lipocine has an alpha of 1.0109, implying that it can generate a 1.01 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 5.13HorizonTargetOdds Above 5.13
99.37%90 days
 5.13 
0.62%
Based on a normal probability distribution, the odds of Lipocine to move above the current price in 90 days from now is near 1 (This Lipocine probability density function shows the probability of Lipocine Stock to fall within a particular range of prices over 90 days) .

Lipocine Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Lipocine that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Lipocine's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Lipocine's value.
InstituionRecorded OnShares
Royal Bank Of Canada2023-12-31
91.0
Fmr Inc2023-12-31
90.0
Advisor Group Holdings, Inc.2023-12-31
68.0
Tidemark Llc2023-12-31
59.0
Group One Trading, Lp2023-12-31
52.0
Wells Fargo & Co2023-12-31
41.0
Jpmorgan Chase & Co2023-12-31
9.0
Bank Of America Corp2023-12-31
6.0
Bridgeway Capital Management, Llc2023-09-30
0.0
Vanguard Group Inc2023-12-31
221.5 K
Blackrock Inc2023-12-31
74.8 K
View Lipocine Diagnostics

Lipocine Historical Income Statement

Lipocine Income Statement is one of the three primary financial statements used for reporting Lipocine's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Lipocine revenue and expense. Lipocine Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Lipocine's Interest Income is very stable compared to the past year. View More Fundamentals

Lipocine Stock Against Markets

Picking the right benchmark for Lipocine stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Lipocine stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Lipocine is critical whether you are bullish or bearish towards Lipocine at a given time. Please also check how Lipocine's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Lipocine without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Share Portfolio Now

   

Share Portfolio

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Lipocine Corporate Directors

Lipocine corporate directors refer to members of a Lipocine board of directors. The board of directors generally takes responsibility for the Lipocine's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Lipocine's board members must vote for the resolution. The Lipocine board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Richard OnoDirectorProfile
Jeffrey FinkDirectorProfile
Stephen HillLead Independent DirectorProfile
John HiguchiNon-Executive DirectorProfile

How to buy Lipocine Stock?

Before investing in Lipocine, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Lipocine. To buy Lipocine stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Lipocine. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Lipocine stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Lipocine stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Lipocine stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Lipocine, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Lipocine Stock please use our How to Invest in Lipocine guide.

Already Invested in Lipocine?

The danger of trading Lipocine is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Lipocine is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Lipocine. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Lipocine is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Lipocine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lipocine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lipocine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lipocine Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipocine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.
Note that the Lipocine information on this page should be used as a complementary analysis to other Lipocine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Lipocine Stock analysis

When running Lipocine's price analysis, check to measure Lipocine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipocine is operating at the current time. Most of Lipocine's value examination focuses on studying past and present price action to predict the probability of Lipocine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipocine's price. Additionally, you may evaluate how the addition of Lipocine to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Is Lipocine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.14)
Revenue Per Share
(0.54)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.37)
Return On Equity
(0.58)
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.